Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen for Inflammation After Acute Muscle Injury
NCT06274151Not yet recruiting
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Feb 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of naproxen in muscle strain (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Effect of anti-inflammatory medicine on cellular profile in skeletal muscle at 12 months. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
naproxen
03
Conditions
muscle strain
Beyond the preview
Go deeper on NCT06274151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06274151.